The mixed lineage kinase-3 inhibitor URMC-099 improves therapeutic outcomes for long-acting antiretroviral therapy by Zhang, Gang, PhD, Guo, Dongwei, MS, Dash, Prasanta K., PhD, Araínga, Mariluz, DVM, MSc, PhD, Wiederin, Jayme L., MS, Haverland, Nicole A., PhD, Knibbe-Hollinger, Jaclyn, MPH, Martinez-Skinner, Andrea, PhD, Ciborowski, Pawel, PhD, Goodfellow, Val S., PhD, Wysocki, Tadeusz A., PhD, Wysocki, Beata J., PhD, Poluektova, Larisa Y., MD, PhD, Liu, Xin-Ming, PhD, McMillan, JoEllyn M., PhD, Gorantla, Santhi, PhD, Gelbard, Harris A., MD, PhD, Gendelman, Howard E., MD

Get full text